Form 8-K - Current report:
SEC Accession No. 0000950170-25-103023
Filing Date
2025-08-05
Accepted
2025-08-05 16:06:31
Documents
11
Period of Report
2025-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bmea-20250805.htm   iXBRL 8-K 45959
2 EX-99.1 bmea-ex99_1.htm EX-99.1 166902
  Complete submission text file 0000950170-25-103023.txt   358934

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bmea-20250805.xsd EX-101.SCH 42867
13 EXTRACTED XBRL INSTANCE DOCUMENT bmea-20250805_htm.xml XML 5985
Mailing Address 1599 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 1599 INDUSTRIAL ROAD SAN CARLOS CA 94070 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)